835PCYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. (23rd October 2018) - Oksala, R; Räsänen, K; Karimaa, M; Riikonen, R; Ramela, M; Vehmaan-Kreula, P; Simola, O; Rummakko, P; Wohlfahrt, G; Mustonen, M